Patents by Inventor Erik Schroeder Handy

Erik Schroeder Handy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7074175
    Abstract: Disclosed are compositions comprising magnetic nanoparticles, a biocompatible coating, and a target-specific ligand. Also disclosed are devices for treating diseased tissue for use with such compositions. Further disclosed are methods for treating diseased tissue, such as cancer, using such compositions and devices, as well as methods for treating diseased tissue utilizing hypertermia.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: July 11, 2006
    Inventors: Erik Schroeder Handy, Robert Ivkov, Diane Ellis-Busby, Allan Foreman
  • Publication number: 20040156846
    Abstract: Methods for treating cells, diseased tissue, pathogens, or other undesirable matter involve the administration of a bioprobe (energy susceptive materials that are attached to the target-specific ligand chimeric L6 antibody) to a patient's body, body part, tissue, or body fluid (such as blood, blood plasma, or blood serum). An energy source provides energy to the bioprobe so as to destroy, rupture, or inactivate the target. Various energy forms, such as AMF, microwave, acoustic, or a combination thereof, created via a variety of mechanisms, may be used. The disclosed methods may be useful in the treatment of a variety of indications, including but not limited to, cancer of any type, such as bone marrow, lung, vascular, neuro, colon, ovarian, breast and prostate cancer.
    Type: Application
    Filed: February 6, 2003
    Publication date: August 12, 2004
    Applicant: Triton Biosystems, Inc.
    Inventors: Wolfgang Daum, Gerald DeNardo, Diane Ellis-Busby, Alan Foreman, Douglas U. Gwost, Erik Schroeder Handy, Robert Ivkov
  • Publication number: 20040156852
    Abstract: Methods for treating cells, diseased tissue, pathogens, or other undesirable matter involve the administration of a bioprobe (energy susceptive materials that are attached to a target-specific ligand) to a patient's body, body part, tissue, or body fluid (such as blood, blood plasma, or blood serum). An energy source provides energy to the bioprobe so as to destroy, rupture, or inactivate the target. Various energy forms, such as AMF, microwave, acoustic, or a combination thereof, created via a variety of mechanisms, may be used. The disclosed methods may be useful in the treatment of a variety of indications, including but not limited to, cancer of any type, such as bone marrow, lung, vascular, neuro, colon, ovarian, breast and prostate cancer, AIDS, adverse angiogenesis, restenosis, amyloidosis, tuberculosis, obesity, malaria, and illnesses due to viruses, such as HIV.
    Type: Application
    Filed: February 6, 2003
    Publication date: August 12, 2004
    Applicant: Triton Biosystems, Inc.
    Inventors: Wolfgang Daum, Diane Ellis-Busby, Alan Foreman, Robert C. Goldstein, Douglas U. Gwost, Erik Schroeder Handy, Robert Ivkov, Valentin S. Nemkov
  • Publication number: 20030028071
    Abstract: Disclosed are compositions comprising magnetic nanoparticles, a biocompatible coating, and a target-specific ligand. Also disclosed are devices for treating diseased tissue for use with such compositions. Further disclosed are methods for treating diseased tissue, such as cancer, using such compositions and devices, as well as methods for treating diseased tissue utilizing hypertermia.
    Type: Application
    Filed: June 18, 2002
    Publication date: February 6, 2003
    Applicant: Triton Biosystems, Inc.
    Inventors: Erik Schroeder Handy, Robert Ivkov, Diane Ellis-Busby, Allan Foreman